Drugs / Sofosbuvir/Velpatasvir/Voxilaprevir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03619837 | Jul 2018 → Dec 2019 | disease related to solid organ transplantation, hepatitis C virus infection | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sofosbuvir/Velpatasvir/Voxilaprevir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03619837 ↗ |